News & Analysis as of

Interim Final Rules (IFR) Food and Drug Administration (FDA) Department of Health and Human Services (HHS)

Akin Gump Strauss Hauer & Feld LLP

Akin Intelligence - September/October 2024

Welcome to the Akin Intelligence September-October recap. Around the one-year anniversary of the AI Executive Order, the White House announced that agencies had carried out their directives. Members of Congress introduced a...more

King & Spalding

He Actually Did It: Trump Administration Implements Medicare Part B “Most Favored Nation” Drug Pricing Reform

King & Spalding on

On November 20, 2020, 60 days before the end of his Administration, President Trump announced a series of major drug pricing regulations. This Alert summarizes the Most Favored Nation Model (“MFN Model”) for Medicare Part B...more

McGuireWoods Consulting

Washington Healthcare Update - November 2020 #2

McGuireWoods Consulting on

This week in Washington: House Minority Leader Kevin McCarthy announced he is waiting to see who will become the next House speaker before working on another COVID-19 stimulus package; Senate Appropriations Committee releases...more

McGuireWoods Consulting

Washington Healthcare Update - October 2020 #5

This week in Washington: Washington is relatively quiet because of Election Day on Tuesday, Nov. 3rd. Grassley, Hassan Introduce Bipartisan Legislation to Increase Transparency and Accountability within the Federal Government...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide